Mangoceuticals Inc. (MGRX)
1.72
-0.38 (-18.10%)
At close: Apr 25, 2025, 3:59 PM
1.73
0.58%
After-hours: Apr 25, 2025, 05:48 PM EDT
Company Description
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform.
It offers erectile dysfunction products under the Mango brand name.
The company sells its products through online website mangorx.com.
Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas.
Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Mangoceuticals Inc.
| Country | United States |
| IPO Date | Mar 21, 2023 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Jacob D. Cohen |
Contact Details
Address: 15110 North Dallas Parkway Dallas, Texas United States | |
| Website | https://www.mangorx.com |
Stock Details
| Ticker Symbol | MGRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001938046 |
| CUSIP Number | 56270V106 |
| ISIN Number | US56270V1061 |
| Employer ID | 87-3841292 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Jacob D. Cohen | Co-Founder, Chief Executive Officer & Chairman |
| Amanda Elizabeth Hammer | Chief Operating Officer |
| Eugene M. Johnston | Chief Financial Officer |
| Antonios Isaac | President & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2025 | 8-K | Current Report |
| Apr 11, 2025 | 8-K | Current Report |
| Apr 11, 2025 | SCHEDULE 13D/A | [Amend] Filing |
| Apr 08, 2025 | 8-K | Current Report |
| Apr 02, 2025 | 8-K | Current Report |
| Apr 01, 2025 | S-8 | Filing |
| Mar 28, 2025 | 8-K | Current Report |
| Mar 25, 2025 | 8-K | Current Report |
| Mar 20, 2025 | 10-K | Annual Report |
| Mar 19, 2025 | 8-K | Current Report |